Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Shahid Shah, Sameen Abbas, Irfhan Ali Bin Hyder Ali & Ahmad Salman. (2020) The economic burden of chronic obstructive pulmonary disease (COPD) in the USA, Europe, and Asia: results from a systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 20:6, pages 661-672.
Read now
Read now
Rui Zhang, Jiechen Zhu, Yanan Liu, Yuanqin Li, Wenjing Liu, Maowei Zhang, Bi Chen & Shuyang Zhu. (2020) Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 409-415.
Read now
Read now
Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Read now
Todd P. Gilmer, Bartolome R. Celli, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Maryam Navaie. (2019) Predictors of Nebulized Arformoterol Treatment: A Retrospective Analysis of Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease*. COPD: Journal of Chronic Obstructive Pulmonary Disease 16:2, pages 140-151.
Read now
Read now
Seok Jeong Lee, Seo Woo Kim, Kyoung Ae Kong, Yon Ju Ryu, Jin Hwa Lee & Jung Hyun Chang. (2015) Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 497-506.
Read now
Read now
D van Ranst, WA Stoop, JW Meijer, HJ Otten & IG van de Port. (2014) Reduction of exacerbation frequency in patients with COPD after participation in a comprehensive pulmonary rehabilitation program. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 1059-1067.
Read now
Read now
Articles from other publishers (10)
Kevin I. Duan, Maxwell Birger, David H. Au, Laura J. Spece, Laura C. Feemster & Joseph L. Dieleman. (2023) Health Care Spending on Respiratory Diseases in the United States, 1996–2016. American Journal of Respiratory and Critical Care Medicine 207:2, pages 183-192.
Crossref
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sadia Shakeel, Ong Siew Chin, Irfhan Ali Bin Hyder Ali, Jaya Muneswarao & Rabia Hussain. (2020) Economic Burden of Chronic Obstructive Pulmonary Disease Patients in Malaysia: A Longitudinal Study. PharmacoEconomics - Open 5:1, pages 35-44.
Crossref
Crossref
Garrett Pehote & Neeraj Vij. (2020) Autophagy Augmentation to Alleviate Immune Response Dysfunction, and Resolve Respiratory and COVID-19 Exacerbations. Cells 9:9, pages 1952.
Crossref
Crossref
Anna E. WallaceShuchita KailaValentina BayerAsif ShaikhMayura U. ShindeVincent J. WilleyMark B. NapierJoseph R. Singer. (2019) Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population. Journal of Managed Care & Specialty Pharmacy 25:2, pages 205-217.
Crossref
Crossref
John M. Chapel, Matthew D. Ritchey, Donglan Zhang & Guijing Wang. (2017) Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries. American Journal of Preventive Medicine 53:6, pages S143-S154.
Crossref
Crossref
Huimin Wu, Robert A. Wise & Ann E. Medinger. (2017) Do Patients Hospitalized With COPD Have Airflow Obstruction?. Chest 151:6, pages 1263-1271.
Crossref
Crossref
Gloria Westney, Marilyn G. Foreman, Junjun Xu, Marshaleen Henriques King, Eric Flenaugh & George Rust. (2017) Impact of Comorbidities Among Medicaid Enrollees With Chronic Obstructive Pulmonary Disease, United States, 2009. Preventing Chronic Disease 14.
Crossref
Crossref
Matthias Vogl & Reiner Leidl. (2015) Informing management on the future structure of hospital care: an extrapolation of trends in demand and costs in lung diseases. The European Journal of Health Economics 17:4, pages 505-517.
Crossref
Crossref
Taulant Muka, David Imo, Loes Jaspers, Veronica Colpani, Layal Chaker, Sven J. van der Lee, Shanthi Mendis, Rajiv Chowdhury, Wichor M. Bramer, Abby Falla, Raha Pazoki & Oscar H. Franco. (2015) The global impact of non-communicable diseases on healthcare spending and national income: a systematic review. European Journal of Epidemiology 30:4, pages 251-277.
Crossref
Crossref
Tzahit Simon-Tuval & Nimrod Maimon. (2015) Tiotropium as part of inhaled polytherapy: Adherence and associated health-care utilization. Respirology 20:2, pages 304-311.
Crossref
Crossref